The Importance of Combined Antithrombotic Treatment for Capsular Warning Syndrome

被引:8
|
作者
Kamo, Hikaru [1 ]
Miyamoto, Nobukazu [1 ]
Otani, Hana [1 ]
Kurita, Naohide [1 ]
Nakajima, Sho [1 ]
Ueno, Yuji [1 ]
Yamashiro, Kazuo [1 ]
Tanaka, Ryota [1 ]
Hattori, Nobutaka [1 ]
机构
[1] Juntendo Univ Hosp, Dept Neurol, Bunkyo Ku, Tokyo, Japan
来源
关键词
Capsular warning syndrome; dual antiplatelet therapy; transient ischemic attack; hemodynamic infarction; lacunar symptoms; CLOPIDOGREL; STROKE; RECURRENCE; ASPIRIN; THERAPY;
D O I
10.1016/j.jstrokecerebrovasdis.2018.06.038
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: Capsular warning syndrome (CWS) is characterized by recurrent conventional episodes of motor and/or sensory deficits without cortical symptoms. The purpose of this case series study was to evaluate the safety and appropriate treatment for CWS to prevent the development of complete stroke. Methods: We reviewed our hospital records and previous reports to find patients with neurologically fluctuating profiles, and excluded those with unknown details of initial treatment/final treatment of antiplatelet therapy or radiological findings. Results: We retrieved two cases of CWS from our hospital, which presented motor and/or sensory symptoms followed by complete resolution without complete ischemia. The recurring episodes in both were unable to be stabilized by single antiplatelet therapy but were successfully managed using two or more antiplatelet drugs. In 11 previously reported cases of CWS, the recurring episode was frequency stabilized with plural antiplatelet therapy. Conclusion: Multiplicate antiplatelet therapy is important for treatment of CWS, and caution is needed regarding hemorrhagic complications.
引用
收藏
页码:3095 / 3099
页数:5
相关论文
共 50 条
  • [1] Combined Antithrombotic Treatment With Aspirin and Clopidogrel for Patients With Capsular Warning Syndrome A Case Report
    Asil, Talip
    Ir, Nasif
    Karaduman, Fatih
    Cagli, Bekir
    Tuncel, Sedat
    NEUROLOGIST, 2012, 18 (02) : 68 - 69
  • [2] rt-PA with Antithrombotic Therapies in a Case with Capsular Warning Syndrome
    Fuseya, Yasuhiro
    Kawamura, Miyuki
    Matsuda, Eri
    Takada, Kozue
    Watanabe, Kiwamu
    Fujitake, Junko
    Nakaya, Yoshifumi
    INTERNAL MEDICINE, 2017, 56 (04) : 441 - 444
  • [3] Combined Atherothrombotic Therapy for a Patient with Capsular Warning Syndrome
    Kawano, Hiroyuki
    Nakajima, Makoto
    Inatomi, Yuichiro
    Yonehara, Toshiro
    Ando, Yukio
    CEREBROVASCULAR DISEASES, 2013, 36 : 34 - 34
  • [4] Loading Dose of Clopidogrel in Combination with Other Antithrombotic Therapy for Capsular Warning Syndrome
    Kawano, Hiroyuki
    Nakajima, Makoto
    Inatomi, Yuichiro
    Yonehara, Toshiro
    Ando, Yukio
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (05): : 1265 - 1266
  • [5] Capsular warning syndrome: clinical analysis and treatment
    He, Lanying
    Xu, Ronghua
    Wang, Jian
    Zhang, Lili
    Zhang, Lijuan
    Zhou, Fangfang
    Dong, Weiwei
    BMC NEUROLOGY, 2019, 19 (01)
  • [6] Capsular warning syndrome: clinical analysis and treatment
    Lanying He
    Ronghua Xu
    Jian Wang
    Lili Zhang
    Lijuan Zhang
    Fangfang Zhou
    Weiwei Dong
    BMC Neurology, 19
  • [7] CAPSULAR WARNING SYNDROME
    FREY, JL
    NEUROLOGY, 1994, 44 (01) : 195 - 195
  • [8] Thrombolysis in capsular warning syndrome
    Gonzalez Hernandez, Ayoze
    Fabre Pi, Oscar
    Lopez Fernandez, Juan Carlos
    Diaz Nicolas, Santiago
    MEDICINA CLINICA, 2010, 134 (13): : 612 - 613
  • [9] Thrombolysis in capsular warning syndrome
    Vivanco-Hidalgo, Rosa Maria
    Rodriguez-Campello, Ana
    Ois, Angel
    Cucurella, Gracia
    Pont-Sunyer, Claustre
    Gomis, Meritxell
    Cuadrado-Godia, Elisa
    Roquer, Jaume
    CEREBROVASCULAR DISEASES, 2008, 25 (05) : 508 - 510
  • [10] The Capsular Warning Syndrome Reconsidered
    Springer, Mellanie V.
    Labovitz, Daniel L.
    CEREBROVASCULAR DISEASES, 2013, 36 (02) : 152 - 152